SCHEMBL6979722

SCHEMBL6979722

N#Cc1ccc(CCC(=O)N2CCCc3cc(N)ccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.48
PDK1 Q15118 1/20 0.47
PDK2 Q15119 1/20 0.47
PDK3 Q15120 1/20 0.47
PDK4 Q16654 1/20 0.47
TSHR P16473 2/20 0.45
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HDAC1 Q13547 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
BRD4 O60885 1/20 0.43
ATAD2 Q6PL18 1/20 0.43
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7959087 0.98 TP53 (0.48) TP53PDK1PDK2PDK3PDK4
SCHEMBL6975443 0.93 TP53 (0.54) TP53TSHRMEN1ALDH1A1KMT2A
SCHEMBL6986711 0.88 TSHR (0.45) TP53PDK1PDK2PDK3PDK4
SCHEMBL6979462 0.85 MAPT (0.58) TP53TSHRMEN1USP2ALDH1A1
SCHEMBL6979360 0.84 TP53 (0.42) TP53TSHRMEN1USP2ALDH1A1
SCHEMBL6986432 0.84 TP53 (0.48) TP53TSHRMEN1USP2ALDH1A1
SCHEMBL6985487 0.83 TP53 (0.41) TP53TSHRMEN1USP2ALDH1A1
SCHEMBL6981640 0.83 NR3C1 (0.47) TP53TSHRMEN1USP2ALDH1A1
SCHEMBL6978707 0.83 MAPT (0.58) TP53TSHRMEN1USP2ALDH1A1
SCHEMBL6981826 0.82 PDK1 (0.52) TP53PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed